Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

A Mouse Model of SARS-CoV-2 Infection and Pathogenesis.

Tytuł:
A Mouse Model of SARS-CoV-2 Infection and Pathogenesis.
Autorzy:
Sun SH; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences (AMMS), Beijing 100071, China.
Chen Q; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences (AMMS), Beijing 100071, China.
Gu HJ; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences (AMMS), Beijing 100071, China.
Yang G; State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Science(Beijing), Beijing Institute of Lifeomics, Beijing 102206, China.
Wang YX; State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Science(Beijing), Beijing Institute of Lifeomics, Beijing 102206, China.
Huang XY; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences (AMMS), Beijing 100071, China.
Liu SS; Division of Animal Model Research, Institute for Laboratory Animal Resources, National Institutes for Food and Drug Control, Beijing 102629, China.
Zhang NN; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences (AMMS), Beijing 100071, China.
Li XF; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences (AMMS), Beijing 100071, China.
Xiong R; Division of Animal Model Research, Institute for Laboratory Animal Resources, National Institutes for Food and Drug Control, Beijing 102629, China.
Guo Y; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences (AMMS), Beijing 100071, China.
Deng YQ; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences (AMMS), Beijing 100071, China.
Huang WJ; Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing 102629, China.
Liu Q; Division of Animal Model Research, Institute for Laboratory Animal Resources, National Institutes for Food and Drug Control, Beijing 102629, China.
Liu QM; Division of Animal Model Research, Institute for Laboratory Animal Resources, National Institutes for Food and Drug Control, Beijing 102629, China.
Shen YL; Beijing Biocytogen Co., Ltd., Beijing 101111, China.
Zhou Y; Chongqing Weisiteng Biotech Transnational Research Institute, Chongqing 400039, China.
Yang X; State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Science(Beijing), Beijing Institute of Lifeomics, Beijing 102206, China.
Zhao TY; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences (AMMS), Beijing 100071, China.
Fan CF; Division of Animal Model Research, Institute for Laboratory Animal Resources, National Institutes for Food and Drug Control, Beijing 102629, China.. Electronic address: .
Zhou YS; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences (AMMS), Beijing 100071, China. Electronic address: .
Qin CF; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences (AMMS), Beijing 100071, China. Electronic address: .
Wang YC; Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing 102629, China. Electronic address: .
Źródło:
Cell host & microbe [Cell Host Microbe] 2020 Jul 08; Vol. 28 (1), pp. 124-133.e4. Date of Electronic Publication: 2020 May 27.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Original Publication: Cambridge, Mass. : Cell Press
MeSH Terms:
Coronavirus Infections*/pathology
Coronavirus Infections*/virology
Disease Models, Animal*
Mice, Inbred C57BL*
Pandemics*
Pneumonia, Viral*/pathology
Pneumonia, Viral*/virology
Betacoronavirus/*physiology
Aging ; Angiotensin-Converting Enzyme 2 ; Animals ; Brain/virology ; COVID-19 ; CRISPR-Cas Systems ; Cytokines/blood ; Gene Knock-In Techniques ; Lung/pathology ; Lung/virology ; Lung Diseases, Interstitial/pathology ; Nose/virology ; Peptidyl-Dipeptidase A/genetics ; Peptidyl-Dipeptidase A/metabolism ; RNA, Viral/analysis ; SARS-CoV-2 ; Stomach/virology ; Trachea/virology ; Viral Load ; Virus Replication
References:
Nature. 2020 Mar;579(7798):270-273. (PMID: 32015507)
Lancet. 2020 Feb 22;395(10224):565-574. (PMID: 32007145)
J Virol. 2007 Feb;81(3):1162-73. (PMID: 17108019)
N Engl J Med. 2020 Feb 20;382(8):727-733. (PMID: 31978945)
JAMA. 2020 Mar 17;323(11):1061-1069. (PMID: 32031570)
Clin Infect Dis. 2020 Sep 12;71(6):1547-1551. (PMID: 32112072)
Gut. 2020 Jun;69(6):1002-1009. (PMID: 32213556)
J Virol. 2007 Jan;81(2):813-21. (PMID: 17079315)
Nature. 2020 Jul;583(7818):830-833. (PMID: 32380511)
N Engl J Med. 2020 Apr 16;382(16):1564-1567. (PMID: 32182409)
Lancet. 2020 Feb 15;395(10223):507-513. (PMID: 32007143)
Nat Med. 2004 Mar;10(3):290-3. (PMID: 14981511)
Nature. 2020 Mar;579(7798):265-269. (PMID: 32015508)
Lancet Gastroenterol Hepatol. 2020 Apr;5(4):335-337. (PMID: 32087098)
N Engl J Med. 2020 Mar 26;382(13):1199-1207. (PMID: 31995857)
Clin Infect Dis. 2020 Jul 28;71(15):769-777. (PMID: 32176772)
J Virol. 2008 Aug;82(15):7264-75. (PMID: 18495771)
Lancet. 2020 Mar 28;395(10229):1054-1062. (PMID: 32171076)
Cell. 2020 Apr 16;181(2):281-292.e6. (PMID: 32155444)
N Engl J Med. 2012 Nov 8;367(19):1814-20. (PMID: 23075143)
Nat Rev Microbiol. 2009 Mar;7(3):226-36. (PMID: 19198616)
Nature. 2003 Nov 27;426(6965):450-4. (PMID: 14647384)
Nature. 2020 May;581(7807):221-224. (PMID: 32225175)
Gut. 2020 Jun;69(6):997-1001. (PMID: 32241899)
Adv Virol. 2011;2011:734690. (PMID: 22312351)
J Infect Dis. 2010 Apr 1;201(7):993-9. (PMID: 20187747)
Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):3048-53. (PMID: 26976607)
Biochem Biophys Res Commun. 2020 May 21;526(1):135-140. (PMID: 32199615)
Nat Rev Microbiol. 2019 Mar;17(3):181-192. (PMID: 30531947)
Lancet. 2020 Feb 15;395(10223):497-506. (PMID: 31986264)
Euro Surveill. 2013 Sep 19;18(38):. (PMID: 24084338)
Nat Commun. 2020 Mar 27;11(1):1620. (PMID: 32221306)
Front Med. 2020 Apr;14(2):185-192. (PMID: 32170560)
Cell. 2020 May 14;181(4):905-913.e7. (PMID: 32333836)
Lancet Respir Med. 2020 May;8(5):475-481. (PMID: 32105632)
Nature. 2020 May;581(7807):215-220. (PMID: 32225176)
Lancet. 2003 Apr 19;361(9366):1319-25. (PMID: 12711465)
Comp Med. 2007 Oct;57(5):450-9. (PMID: 17974127)
Nat Med. 2020 Apr;26(4):502-505. (PMID: 32284613)
Contributed Indexing:
Keywords: SARS-CoV-2; angiotensin-converting enzyme II; hACE2-KI/NIFDC; mouse model; pathogenesis
Substance Nomenclature:
0 (Cytokines)
0 (RNA, Viral)
EC 3.4.15.1 (Peptidyl-Dipeptidase A)
EC 3.4.17.23 (ACE2 protein, human)
EC 3.4.17.23 (Ace2 protein, mouse)
EC 3.4.17.23 (Angiotensin-Converting Enzyme 2)
Entry Date(s):
Date Created: 20200603 Date Completed: 20200717 Latest Revision: 20210110
Update Code:
20240104
PubMed Central ID:
PMC7250783
DOI:
10.1016/j.chom.2020.05.020
PMID:
32485164
Czasopismo naukowe
Since December 2019, a novel coronavirus SARS-CoV-2 has emerged and rapidly spread throughout the world, resulting in a global public health emergency. The lack of vaccine and antivirals has brought an urgent need for an animal model. Human angiotensin-converting enzyme II (ACE2) has been identified as a functional receptor for SARS-CoV-2. In this study, we generated a mouse model expressing human ACE2 (hACE2) by using CRISPR/Cas9 knockin technology. In comparison with wild-type C57BL/6 mice, both young and aged hACE2 mice sustained high viral loads in lung, trachea, and brain upon intranasal infection. Although fatalities were not observed, interstitial pneumonia and elevated cytokines were seen in SARS-CoV-2 infected-aged hACE2 mice. Interestingly, intragastric inoculation of SARS-CoV-2 was seen to cause productive infection and lead to pulmonary pathological changes in hACE2 mice. Overall, this animal model described here provides a useful tool for studying SARS-CoV-2 transmission and pathogenesis and evaluating COVID-19 vaccines and therapeutics.
Competing Interests: Declaration of Interests The authors declare no competing interests.
(Copyright © 2020 Elsevier Inc. All rights reserved.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies